Verition Fund Management
OACC

Verition Fund Management’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Verition Fund Management’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.04M Buy
470,342
+165,294
+54% +$1.76M 0.03% 655
2026
Q1 		$3.24M Sell
305,048
-4,692
-2% -$50K 0.02% 766
2025
Q4 		$3.29M Buy
309,740
+148,000
+92% +$1.57M 0.01% 1181
2025
Q3 		$1.69M Buy
161,740
+10,117
+7% +$106K 0.01% 2116
2025
Q2 		$1.59M Buy
151,623
+4,774
+3% +$49.5K 0.01% 2119
2025
Q1 		$1.5M Sell
146,849
-53,151
-27% -$533K 0.01% 1793
2024
Q4 		$2M Buy
+200,000
New +$2M 0.01% 1554

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BGGS
Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Verition Fund Management's OACC Position: Q2 2026 in Review

Verition Fund Management increased its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 54% in Q2 2026, buying an estimated $1.76M and bringing the position to 470,342 shares worth $5.04M. The position accounts for 0.03% of the portfolio, ranked #655.

Verition Fund Management first reported a position in OACC in Q4 2024 and has held it in 7 quarters since. 51 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

  • Verition Fund Management held 470,342 shares of Oaktree Acquisition Corp III Life Sciences worth $5.04M as of Q2 2026.
  • Verition Fund Management bought 165,294 Oaktree Acquisition Corp III Life Sciences shares in Q2 2026, an estimated $1.76M.
  • Oaktree Acquisition Corp III Life Sciences made up 0.03% of Verition Fund Management's portfolio in Q2 2026, its #655 holding.
  • Verition Fund Management first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and has held it in 7 quarters since.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.